Basic fibroblast growth factor confers growth inhibition and mitogen-activated protein kinase activation in human breast cancer cells

Clinical Cancer Research

Volumn 3, Issue 1, 1997, Pages 135-142

  Fenig, Eyal ^a   Wieder, Robert ^b   Paglin, Shoshana ^a   Wang, Huisheng ^b   Persaud, Roger ^a   Haimovitz Friedman, Adriana ^a   Fuks, Zvi ^a   Yahalom, Joachim ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; ESTRADIOL; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; RECOMBINANT FIBROBLAST GROWTH FACTOR;

ARTICLE; BREAST CANCER; CELL CULTURE; CELL CYCLE; CELL LINE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG BINDING; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL;

BINDING SITES; BREAST NEOPLASMS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CELL CYCLE; CELL DIVISION; DNA; ENZYME ACTIVATION; FIBROBLAST GROWTH FACTOR 2; GROWTH INHIBITORS; HUMANS; IODINE RADIOISOTOPES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; TUMOR CELLS, CULTURED;

EID: 0031041971     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Burgess, W. H., and Maciagn, T. The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem., 58: 575-606, 1989.
2. Rifkin, D. B., and Moscatelli, D. Recent developments in the cell biology of basic fibroblast growth factor. J. Cell Biol., 109: 1-6, 1989.
3. Gospodarowicz, D., Ferrara, N., Schweigerer, L., and Neufeld, G. Structural characterization and biological functions of fibroblast growth factor. Endocr. Rev., 8: 1-20, 1987.
4. Stewart, A. J., Westley, B. R., and May, F. E. B. Modulation of the proliferate response of breast cancer cells to growth factors by oestrogen. Br. J. Cancer, 66: 640-648, 1992.
5. Briozzo, P., Badet, J., Capony, F., Pieri, I., Montcourrier, P., Barritault, D., and Rochefort, H. MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. Exp. Cell Res., 194: 252-259, 1991.
6. Karey, K. P., and Sirbasku, D. A. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17β-estradiol. Cancer Res., 48: 4083-4092, 1988.
7. Peyrat, P. J., Hondermark, H., Louchez, M. M., and Biolly, B. Demonstration of basic fibroblast growth factor high and low affinity binding sites in human breast cancer. Cancer Commun., 3: 323-329, 1991.
8. Neufeld, G., and Gospodarowicz, D. The identification and partial characterization of the fibroblast growth factor receptor of baby hamster kidney cells. J. Biol. Chem., 260: 3860-3868, 1985.
9. Raz, V., Kelman, Z., Avivi, A., Neufeld, G., Givol, D., and Yarden, Y. PCR-based identification of new receptors: molecular cloning of a receptor for fibroblast growth factors. Oncogene, 6: 753-760, 1991.
10. Dionne, G. A., Crumley, G., Bellot, F., Kaplow, J. M., Scartoff, G., Ruta, M., Burgess, W. H., Jaye, M., and Schlessinger, J. Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J., 9: 2685-2692, 1990.
11. Givol, D. and Yayon, A. Complexity of FGF receptors; genetic basis for structural diversities and functional specificity. FASEB J., 6: 3362-3369, 1992.
12. Johnson, D. E., and Williams, L. T. Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res., 60: 1-41, 1993.
13. MAPK are required for fibroblast proliferation. Proc. Natl. Acad. Sci. USA, 90: 8319-8323, 1993.
14. Anderson, N. G., Mailer, J. L., Tonks, N. K., and Strugill, T. W. Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAPKinase. Nature (Lond.), 343: 651-653, 1990.
15. Lippman, M. E., Bolan, G., and Huff, K. K. The effect of estrogens and antiestrogens on hormone responsive breast cancer in long term culture. Cancer Res., 36: 4595-5601, 1976.
16. McLeskey, S. W., Ding, I., Y. F., Lippman, M. E., and Kern, F. G. MDA-MB-134 breast carcinoma cells overexpressed fibroblast growth factor (FGF) receptors and are growth-inhibited by FGF ligands. Cancer Res., 54: 523-530, 1994.
17. Dabre, P., Yates, J., Curtis, S., and King, R. J. B. Effect of estradiol on human breast cancer cells in culture. Cancer Res., 43: 349-354, 1983.
18. Gospodarowicz, D., Moran, J., Braun, D., and Birdwell, C. Clonal growth of bovine aortic endothelial cells: fibroblast growth factor as a survival agent. Proc. Natl. Acad. Sci. USA, 73: 4120-4124, 1976.
19. Gray, G. W., and Coffino, P. Cell cycle analysis by flow cytometry. Methods Enzymol., 58: 233-248, 1979.
20. McConahey, P. J., and Dixon, F. J. Radioiodination of proteins by the use of the chloramine-T methods. Methods Enzymol., 70: 210-213, 1980.
21. Vaisman, N., Gospodorowicz, D., and Neufeld, G. Characterization of the receptor for vascular endothelial growth factor. J. Biol. Chem., 265: 19461-19466, 1990.
22. Moscatelli, D. High and low affinity binding sites for basic fibreblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J. Cell. Physiol., 131: 123-130, 1987.
23. Raines, M. A., Golde, D. W., Daeipour, M., and Nel, A. E. Granulocyte-macrophage colony-stimulating factor activated microtubule-associated protein 2 kinases in neutrophils via a tyrosine kinase-dependent pathway. Blood, 79: 3350-3354, 1992.
24. Hutchcroft, J. E., Anostasrio, M., Harrison, M. L., and Geahlen, R. L. Renaturation and assay of protein kinases after electrophoresis in sodium dodecyl sulfate-polyacrylamide gels. Methods Enzymol., 200: 417-423, 1991.
25. Kameshita, I., and Fujisawa, H. A sensitive method for detection of calmodulin-dependent protein kinase II activity in sodium dodecyl sulfate-polyacrylamide gel. Anal. Biochem., 183: 139-143, 1989.
26. Scatchard, G. The attractions of proteins for small molecules and ions. Ann. NY Acad. Sci., 51: 660-672, 1949.
27. Neufeld, G., and Gospodarowicz, D. Basic and acidic fibroblast growth factors interact with the same cell surface receptors. J. Biol. Chem., 261: 5631-5637, 1986.
28. Leevers, S. J., and Marshall, C. J. Activation of extracellular signal-related kinase, ERK2, by p21 ras oncoprotein. EMBO J., 11: 569-574, 1992.
29. Schweigerer, L., Neufeld, G., and Gospodarowicz, D. Basic fibroblast growth factor as a growth inhibitor for cultured human tumor cells. J. Clin. Invest., 80: 1516-1520, 1987.
30. Zhou, J., and Serrera, G. Fibroblast growth factor inhibits proliferation of a highly tumorigenic insulin-independent teratoma-derived cell line. Growth Factor, 9: 123-131, 1993.
31. Haimovitz-Friedman, A., Kan, C. C., Ehleiter, D., Persaud, R. S., McLoughlin, M., Fuks, Z., and Kolesnick, R. N. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J. Exp. Med., 180: 525-535, 1994.
32. Jarvis, W. D., Fornari, F. A., Jr., Browning, J. L., Gewirtz, D. A., Kolesnick, R. N., and Grant, S. Attenuation of ceramide-induced apoptosis by diglyceride in human myeloid leukemia cells. J. Biol. Chem., 269: 31685-31692, 1994.
33. Obeid, L. M., Linardic, C. M., Karolak, L. A., and Hannun, Y. A. Programmed cell death induced by ceramide. Science (Washington DC), 259: 1769-1771, 1993.
34. Kolesnick, R., and Fuks, Z. Ceramide: a signal for apoptosis or mitogenesis? (Review). J. Exp. Med., 181: 1949-1952, 1995.
35. Ullrich, A., and Schlessinger, J. Signal transduction by receptors with tyrosine kinase activity. Cell, 61: 203, 1990.
36. Nishizuka, Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C (Review). Science (Washington DC), 258: 607-614, 1992.
37. Mohamandi, M., Dionne, C. A., Li, W., Li, N., Spivak, T., Honegger, A. M., Jaye, M., and Schlessinger, J. Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis. Nature (Lond.), 358: 681-684, 1992.
38. +2 flux but not mitogenesis. Nature (Lond.), 358: 678-681, 1992.
39. Wang, J. K., Gao, G., and Goldfarb, M. Fibroblast growth factor receptors have different signaling and mitogenic potentials. Mol. Cell. Biol., 14: 181-188, 1994.
40. Paris, S., and Pouyssegur, J. Mitogenic effects of fibroblast growth factors in cultured fibroblasts. Interaction with the G-protein-mediated signaling pathways (Review). Ann. NY Acad. Sci., 638: 139-148, 1991.
41. Huang, J., Mohammadi, M., Rodrigues, G. A., and Schlessinger, J. Reduced activation of RAF-1 and MAP kinase by a fibroblast growth factor receptor mutant deficient in stimulation of phosphatidylinositol hydrolysis. J. Biol. Chem., 270; 5065-5072, 1995.